MoVax develops oral vaccines. The vaccine survives the gastrointestinal tract because of bio-encapsulation the API inside microbial cells. Microalgae are a highly promising delivery platform for oral vaccines.

At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.

Nanoporous MicroNeedle Arrays (npMNAs), integrated into a patch for drug delivery through the skin

MyMicroZoo™ is a company that offers microbiome analysis and web-based tools to gather meta-data (e.g. age, health-status, exercise logs, etc.) as service to the general public, allowing them to gain knowledge and understanding of their microbiota through an innovative platform.

NatInLab develops promising compounds to battle Alzheimer's disease. We expect the compounds to be curative and show minimal side effects.

Stem cell technologies help bring better therapies to patients faster. Ncardia works with pharmaceutical and cell therapy companies worldwide to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities.

NeoStartTrack is an innovative medical device that will give instant feedback on ventilation effectiveness and heart rate range. This enables direct and adequate adaptation of treatment.

At NestEgg Labs, we simplify 3D cell culture through automation. We have developed Ovation, an automated platform capable of combining Lens-Free Imaging technology for constant cell monitoring and flexible fluid handling for cell maintenance inside a controlled environment, letting cells grow without unnecessary manual interference.

NightBalance is a compact, easy-to-use maskless treatment against positional OSA. you wear the small device comfortably on your chest in a soft, adjustable chest strap.